Background: The severity and predictors of functional disability and health-related quality of life
(p=0.03), high baseline pain (p=0.02) and HAQ (p=0.04) predicted suboptimal mental health, with a trend towards low level of schooling being significant (p=0.08). Conclusions: Early RA has a broad impact on HRQoL in indigent South Africans, with a large proportion of patients still showing substantial functional disability and suboptimal mental health despite 12 months of DMARD therapy. Further research is needed to establish the role of interventions including psycho-social support, rehabilitation programmes and biologic therapy to improve physical function and HRQoL in this population.
Keywords functional disability, health-related quality of life, South Africa, socio-economic status Joint inflammation and consequent damage can potentially cause serious disability in rheumatoid arthritis (RA). Modern RA therapy is aimed at restoring activities of daily life, psychological health, and preservation of social and occupational roles through early aggressive control of disease activity. Traditional clinical and laboratory measures of disease activity and severity do not adequately capture aspects of physical disability and psychosocial aspects of the disease(1).
The modified Health Assessment Questionnaire-disability index (HAQ), a disease specific measure of physical disability, and the Medical Outcomes Short Form-36 (SF-36), a generic health-related quality of life (HRQoL) instrument, are widely used self-administered questionnaires in RA (2, 3) . These measures show good correlation with markers of disease activity (4) , especially in early disease; are responsive to treatment (5) ; are good indicators of the indirect costs of RA (6) ; and are predictive of long term disability and mortality (7) . Moreover, instruments that measure HRQoL in RA incorporate the patient's perspective of health status, an aspect that is often overlooked in routine clinical practice (1) .
In established RA, physical function worsens progressively with time, mainly as a consequence of irreversible joint damage (8) and HRQoL is significantly impaired across all domains (9, 10) . By contrast, in early RA, physical disability, as measured by the HAQ, is driven principally by disease activity, specifically synovitis and pain, and improves with effective treatment (11) . General HRQoL, as measured by the SF-36, similarly shows a heavy burden of physical disability and pain with impaired social function, low vitality scores, and poor mental health in early RA (12) (13) (14) .
Socio-demographic and psychosocial factors impact on the overall burden of RA. Low levels of formal education and poor socio-economic status (SES) are risk factors for poorer outcome in RA in industrialized countries (15) (16) (17) . Cross-sectional studies of South Africans with established RA have shown poor HRQoL , impaired functional ability and high rates of depression (18) (19) (20) . Amongst indigent South Africans, access to rheumatology care is limited.
Recognition and referral of early inflammatory arthritis is often delayed at primary care level, and there are few state-sector specialist rheumatology clinics with no access to biologic therapy.
In the absence of any published longitudinal studies of disability and HRQoL in RA in sub-Saharan Africa, we undertook a prospective observational study in South Africans with early RA to evaluate functional disability and HRQoL over 12 months and to identify predictors of poor physical and mental health.
Patients and Methods
A cohort of 171 consenting patients with disease modifying anti-rheumatic drug (DMARD)-naïve early RA, defined as disease duration ≤ 2years, were enrolled between 2005 and 2008 as part of the Gauteng Region Early Arthritis (GREAT) registry. The registry is a multifaceted ongoing project at 2 tertiary state-sector hospitals in Gauteng, South Africa, which serve a mainly indigent urban and peri-urban population. All patients met the modified 1987
American College of Rheumatology classification criteria for RA (21) . Demographic variables collected included age, gender, symptom duration, current employment and the number of school years completed.
The HAQ, SF-36, simplified disease activity Index (SDAI) (22) and a pain, patient global assessment and physician global score were completed at baseline and at 12 months. The minimally clinically important difference (MCID), defined as the smallest improvement in a score that patients perceive as beneficial, of -0.25 and 5 for the HAQ and SF-36 scores respectively, was used (23, 24) . Predictors of functional disability were analyzed by comparing patients with "minimal" functional disability, defined as a HAQ ≤ 0.5, to those with "substantial" functional disability, defined as HAQ > 0.5, at 12 months. The SF-36 mental composite score (MCS) was used as a measure of overall mental health, and an arbitrary cutoff score of 66.6 was used to define patients with "good" mental health (≥66.6) and "suboptimal" mental health (<66.6).
Treatment
Patients were reviewed at 2-4 monthly intervals at routine follow-up visits and treated with DMARDs with or without low-dose prednisone (≤ 7.5mg/day). Changes in DMARD therapy were made at the discretion of the attending physician according to efficacy and tolerance. Poor adherence to therapy was defined as patient's self-reported failure to take DMARDs as prescribed for one month or longer.
Statistical analysis
The Students t test was applied to compare continuous variables between groups, except where the data showed a non-normal distribution, in which case the Wilcoxon rank sum test was used. The Chi-square test, or where indicated, the 2-tailed Fishers' exact test was used for categorical variables. Spearman correlation coefficients were applied to assess correlations between continuous variables. Multivariate analysis was performed using stepwise backward logistic regression, and demographic and baseline variables with a p-value ≤ 0.15 in the univariate analysis were included in the model. A p-value of 0.05 was considered significant. All statistical analyses were done using Stata 10 software (StataCorp, USA).
The study was approved by the University of the Witwatersrand Committee for Research on Human Subjects.
Results

Baseline characteristics
Most patients were female (82%), Black Africans (89%) with a mean (SD) age of 47.0 (12.5) years and symptom duration of 11.6 (7.0) months. Rheumatoid factor and anti-cyclic citrullinated antibodies were positive in 85% and 81% respectively. Patients had severe disease with a mean (SD) SDAI of 39.4 (16.2), HAQ of 1.7 (0.8), and scored low in all domains of the SF-36 with physical composite score (PCS) and MCS scores of 34.2 (16.9) and 44.9 (18.5). The majority were of a poor socio-economic background: the mean number of school years completed was 9 (range 0-12 years); no patient had college or university education and 55% were unemployed.
Therapy and outcome at 12 months
Two patients died of respiratory infections, both in the first 6 months, and 35 (20%) were lost to follow-up. In the remaining 134 patients who completed the 12-month visit, most (91%) were treated with methotrexate as monotherapy or in combination with chloroquine (CQ) and/or sulphasalazine (SSZ), and the remaining patients received SSZ (6%) or CQ monotherapy (3%).
The starting dose of MTX was between 7.5 and 15mg/week (mean (SD) dose 13.1 (3.2) mg/week), and by month 12 the maximum dose was 25mg/week (mean (SD) dose 20.0 (4.3) mg/week). Low dose prednisone (5-7.5mg/day) was prescribed in 90 (52%) patients. There were no cases where the dose of DMARD or prednisone was limited by liver toxicity or septicaemia.
Poor adherence to therapy was observed in almost a quarter of patients.
Improvements in HAQ and SF-36 at 12 months
At 12 months, HAQ and SF-36 scores improved significantly, and the percentage of patients achieving a MCID for the HAQ, SF-36 PCS and MCS was 64, 58 and 43 respectively (Table 1) to selected questions at baseline and at 12 months are shown in Figure 2 . A large proportion of patients continued to experience difficulties in all categories, and in particular showed limitations in lower limb activities (33% of patients were unable to climb a flight of stairs), social activities (25% felt activities were limited by health), and high levels of pain causing interference with daily life (36% had pain intruding on activities of daily living).
Correlations
At 12 months the HAQ correlated significantly with disease activity, pain, patient and physician global assessments (Table 2) , with very strong correlations between the HAQ and the mental subscales of the SF-36. The pain score correlated with the HAQ, and with all SF-36 domains except mental health.
Predictors of 12-month functional disability
Analysis of predictors of response was restricted to the 134 patients who completed the 12 month follow-up visit. Univariate analysis, comparing the minimal functional disability and the substantial functional disability groups, showed that gender, the baseline HAQ and pain scores were significantly different between the groups, with a trend towards a difference in the number of school years, employment rate and adherence to DMARD therapy (Table 3) . At 12 months, patients with minimal functional disability had significantly lower pain and SDAI scores, and had achieved a greater improvement in both pain and disease activity than patients with substantial physical disability.Neither the type nor dose of DMARD therapy, nor whether or not low dose corticosteroids were prescribed predicted the 12 month status.
Multivariate analysis showed that female gender and a high baseline HAQ were independent baseline predictors of substantial functional disability.
Predictors of 12-month mental health status
Univariate analysis, comparing patients who achieved good mental health to those with suboptimal mental health revealed that level of formal education, employment, baseline pain, patient global and HAQ scores were significant (Table 4) . Females fared worse; as did those who were poorly adherent to treatment but these differences did not reach statistical significance, most likely because of the relatively small size of the study. The 12-month pain score, SDAI and HAQ were significantly higher in the patients with suboptimal mental health, and these patients had less improvement in each of these areas. In the multivariate model, unemployment, high baseline HAQ and pain scores were independently associated with suboptimal mental health.
Patients lost to folliow-up
No significant differences in demographics, SDAI, HAQ or SF 36 scores at baseline were observed between the patients who were lost to follow-up versus those who completed the study.
Discussion
To the best of our knowledge, this is the first study to examine longitudinal changes in functional disability and HRQoL in sub-Saharan Africans with RA. It confirms the tremendous burden of early RA on a background of socio-economic depravity. Despite significant improvements in the group overall, more than a third of patients failed to achieve clinically meaningful improvement in physical disability after 12 months of treatment with traditional DMARD therapy and "routine" clinic care. A third of patients continued to struggle to climb a flight of stairs and could not shop for groceries independently, underscoring the difficulties experienced by our patients in performing activities of daily living. A previous cross sectional study of South Africans with established RA shows construct validity of the HAQ and the SF-36 questionnaires in this population, and reports significant physical disability (18) . Elsewhere in the developing world a recent study in Thailand showed significant functional deterioration over 1 year of DMARD therapy (25) .
The central role of pain in our RA patients' symtomatology and its negative impact on physical and social activities is demonstrated by the strong correlations between the pain scores and the HAQ, vitality and social functioning. In a qualitative study Schneider et al found pain to be a key experience of women with RA in Soweto, South Africa where low income and the lack of services compound social exclusion and loss of independence (26) .
Moreover, this study demonstrates the high number of patients with poor mental health, where two thirds of patients had "suboptimal mental health" at their 12-month visit. We observed strong correlations between the mental subscales of the SF-36 including role emotional, vitality and social functioning with the HAQ. These relationships are likely to be bidirectional, as poor functional disability could contribute to suboptimal mental health, but equally, low mood and vitality levels could worsen physical function and perceptions of disability.
Predictors of functional disability and mental health were similar, and included baseline disability, pain and mental health, but not disease activity. These findings are consistent with previous studies, where a poor HAQ score early in the disease is an important predictor of future disability (27) (28) (29) (30) (31) , and pain and depression are major contributors to both physical disability and HRQoL (30, (32) (33) (34) (35) (36) . Poor improvement in pain, disease activity and HAQ scores, and as a result had higher 12-month scores, were associated with worse physical function and mental health scores.
Most patients in this study were of a low SES background, and worse physical and mental health scores were seen amongst unemployed patients and those with less formal education. Previous studies in industrialized countries have shown that fewer years of schooling and poor SES impact negatively on disease activity, mental and emotional health and overall mortality rates (17, 37, 38) . The QUEST-RA studies in 25 countries showed an association between gross domestic product and disease status, including physical disability and psychological health (39) . Margaretten et al refer to a "vulnerable population" of RA patients where background poverty and high functional disability give rise to a high risk for mental illhealth (40) .
Several factors may explain the profound impact of SES on disease expression. Delays in initiating DMARDs may be a reason for poorer outcome amongst indigent patients (41) , and in keeping with this our patients presented relatively late after symptom onset. This is a result of a low awareness of symptoms and available treatments, and limited access to health care. Callahan et al suggest certain lifestyle factors associated with poverty lead to worse health outcomes, some of which may be applicable to our study population -poor diet, less exercise, and low social support (37) . Underutilization of available resources, in particular allied health care, amongst less educated patients has been described in the Netherlands (42) . These aspects were not investigated in the present study, but they may be important factors in our patients. In addition, education may confer better coping skills -and this may mediate illness perception and the overall impact of a chronic illness such as RA (43) .
That females emerged with worse HAQ scores at 12 months is consistent other studies (44, 45) . One explanation is a difference in perception of functional disability, where males underestimate their disability (46) . Almost a quarter of patients admitted poor adherence to their DMARD medication, and these patients fared worse. This has been shown by others (47) .
Whilst previous studies have shown that older age at disease onset is associated with higher physical disability scores (28, 48) , this was not evident in our study, perhaps due to the small proportion of elderly patients in our cohort.
One of the limitations of this study was the high number of patients lost to follow-up, which is probably a reflection of poor SES where financial difficulties and poor public transport facilities make it difficult for patients to keep their follow-up appointments. Another shortcoming is that we did not use a questionnaire to specifically measure depression and relied on the SF-36 MCS to measure mental health. Thirdly, patients included in this study reflect a referral bias where only the more severe patients are referred to tertiary hospitals, and hence results of this study are not generalisable to all South African populations.
This study shows the need for further studies assessing the place of interventions aimed at improving health status of RA patients in this population. These might include physical and occupational therapies and psychosocial support programmes combined with pharmacological treatment of depression and more aggressive therapy of disease per se with biologic drugs. There is evidence for such strategies: antidepressants in depressed patients with musculoskeletal disease have been shown to improve not only mental health status, but physical disability and pain scores (49) , and biologic drug therapy in early RA patients reduces depression and improves outcomes in patients who achieve remission (50) .
In summary, this study demonstrates the broad negative impact of early RA on functional disability and HRQoL in impoverished South African patients. Further studies are required to assess the role of more active rehabilitation and psychosocial support together with hitherto prohibitively costly biologic drugs in this population.
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